Literature DB >> 6205743

The natural history of hepatocellular carcinoma. A study of 100 untreated cases.

N Nagasue, H Yukaya, T Hamada, S Hirose, R Kanashima, K Inokuchi.   

Abstract

The natural course of hepatocellular carcinoma (HCC) was evaluated in 100 untreated patients who were seen during recent 13 years. There were 80 males and 20 females. The macroscopic type of tumor was massive in 58, nodular in 35, and diffuse in 7 cases. Liver cirrhosis was associated with in 80% of patients. The mean survival time of overall patients was 4 months from the onset of initial symptoms to death and 2 months from admission to death. Occult and cirrhotic types of HCC showed a longer survival than frank and febrile types that had a mean survival time of all patients. The prognosis of icteric and metastatic types was poorest. Sex, tumor type, or associated cirrhosis did not substantially affect the natural course of HCC. The tumor stage and clinical stage were grossly correlated to the prognosis. In terms of symptoms, severe jaundice and ascites were the most dismal prognostic signs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205743     DOI: 10.1002/1097-0142(19841001)54:7<1461::aid-cncr2820540740>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  35 in total

1.  The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.

Authors:  Shohei Komatsu; Takumi Fukumoto; Yusuke Demizu; Daisuke Miyawaki; Kazuki Terashima; Yasue Niwa; Masayuki Mima; Osamu Fujii; Ryohei Sasaki; Isamu Yamada; Yuichi Hori; Yoshio Hishikawa; Mitsuyuki Abe; Yonson Ku; Masao Murakami
Journal:  J Gastroenterol       Date:  2011-04-23       Impact factor: 7.527

2.  Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats.

Authors:  T Matsuzaki; N Murase; A Yagihashi; H Shinozuka; Y Shimizu; T Furuya; N Burrell; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1992-04       Impact factor: 1.066

3.  Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma.

Authors:  Hidenari Nagai; Masahiro Kanayama; Katsuya Higami; Kouichi Momiyama; Akiko Ikoma; Naoki Okano; Katsuhiko Matsumaru; Manabu Watanabe; Koji Ishii; Yasukiyo Sumino; Kazumasa Miki
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

4.  Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs.

Authors:  M G van Ijken; E A de Bruijn; G de Boeck; T L ten Hagen; J R van der Sijp; A M Eggermont
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

5.  Clinical decision analysis using microcomputers. A case of coexistent hepatocellular carcinoma and abdominal aortic aneurysm.

Authors:  J B Wong; A J Moskowitz; S G Pauker
Journal:  West J Med       Date:  1986-12

6.  Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.

Authors:  Yuta Sekino; Toshiyuki Okumura; Nobuyoshi Fukumitsu; Takashi Iizumi; Haruko Numajiri; Masashi Mizumoto; Kei Nakai; Tetsuo Nonaka; Hitoshi Ishikawa; Hideyuki Sakurai
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-27       Impact factor: 4.553

Review 7.  Proton Beam Therapy for Hepatocellular Carcinoma: A Review of the University of Tsukuba Experience.

Authors:  Masashi Mizumoto; Yoshiko Oshiro; Toshiyuki Okumura; Nobuyoshi Fukumitsu; Haruko Numajiri; Kayoko Ohnishi; Teruhito Aihara; Hitoshi Ishikawa; Koji Tsuboi; Hideyuki Sakurai
Journal:  Int J Part Ther       Date:  2016-03-24

8.  Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review).

Authors:  Hiroki Ueda; Hiroko Fukuchi; Chigusa Tanaka
Journal:  Oncol Lett       Date:  2011-11-02       Impact factor: 2.967

9.  Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma.

Authors:  Chaur-Shine Wang; Chih-Lin Lin; Hsi-Chang Lee; Kuan-Yang Chen; Ming-Feng Chiang; Hung-Sheng Chen; Tsung-Jung Lin; Li-Ying Liao
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

10.  Transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  C F Yang; Y J Ho
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.